Myriad Pharmaceuticals, Inc. (MYRX) - Financial and Strategic Analysis ReviewMyriad Pharmaceuticals, Inc. (Myriad Pharmaceuticals) is a pharmaceutical company, engaged in the discovery, development, and commercialization of small molecule drug candidates for the medical conditions of cancer and HIV. Its clinical stage pipeline products include Azixa (MPC-6827), MPC-3100, MPC-4326. Azixa is an investigational drug candidate being developed in...more
Earlier, buying a Digital Video Disc player meant causing a deep hole in your purse. Not so anymore, as today they are available at a fraction of their earlier amount. As a matter of fact, Wholesale DVDs are now available for a minimum of $25, which is astonishing. It is all thanks to improvements in tools and entry of China in this marketplace in a big means. Formerly, there were just a small number of large players like Sony and Phillips who...more
Genexine Co., Ltd. (95700) - Financial and Strategic Analysis ReviewGenexine Co., Ltd. (Genexine) is involved in the research and development of therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs such as super-biosimilars. The company's products are used for the therapy areas of anemia, auto-immune diseases, cancer, and diabetes. It also develops DNA vaccines for AIDS and hepatitis B. The company develops its products candidates using hybrid Fc technology, which is an antibody fusion protein production technology. The company also develops biosimilars by utilizing cell strains production system. It has agreements with other pharmacy companies for the development of its product candidates.This comprehensive SWOT profile of Genexine Co., Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This...more
Propharex (PROP) - Financial and Strategic Analysis ReviewPropharex is a specialty pharmaceutical company specialized in the conception, the construction, the delivery and the assembly of "turnkey" modular pharmaceutical plants. The company supplies raw materials to pharmacies which are involved in pharmacy compounding on the Belgian market. While...more
Zhongtian International Limited (2379) - Financial and Strategic Analysis ReviewZhongtian International Limited (Zhongtian International) is an investment holding company engaged in trading of software and hardware products. The company also offers applications and maintenance, system integration and software training services. In addition, the...more
Giaconda Limited (GIA) - Financial and Strategic Analysis ReviewGiaconda Limited (Giaconda) is a research focused biotechnology company, engaged in research, development and commercialization of innovative therapeutics for gastrointestinal diseases and disorders. The company focuses broadly on research and development activities in the area of digestive diseases. The pipeline products of the company includes Myoconda, Hepaconda, Heliconda and Ibaconda, and one bowel evacuant Picoconda. Myoconda is a combination antibiotic therapy being developed in Phase III clinical trial for the treatment of crohns disease. Hepaconda is a combination of bezafibrate and chenodeoxycholic acid.This comprehensive SWOT profile of Giaconda Limited provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of the Profile on Demand...more
CytoDyn, Inc. (CYDY) - Financial and Strategic Analysis ReviewCytoDyn, Inc. (CytoDyn) is a biotechnology research company that is engaged in the development of drugs to treat HIV/AIDS. The company is a member of New Mexico Biotechnology and...more
Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic Analysis ReviewIntellect Neurosciences, Inc. (Intellect Neuro) is a US based biopharmaceutical company. Intellect Neuro is in development stage. The company is engaged in the discovery...more
QRxPharma Limited (QRX) - Financial and Strategic Analysis ReviewQRxPharma Limited (QRxPharma) is clinical-stage specialty pharmaceutical company. The company is engaged in the development, manufacture and sale of products pertaining to pain...more
Omeros Corporation (OMER) - Financial and Strategic Analysis ReviewOmeros Corporation (Omeros) is the US based clinical-stage bio-pharmaceutical company. It is engaged in the discovery, development and commercialization of products which are focused...more
Sosei Co. Ltd. (4565) - Financial and Strategic Analysis ReviewSosei Co. Ltd., (Sosei)is a privately held company that is engaged in the process of drug development. The product pipeline of the company is supplemented by in-licensing agreements for...more
Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic Analysis ReviewLaboratorios Farmaceuticos ROVI, S.A. (Laboratorios Farmaceuticos) is a chemical and pharmaceutical company. The company is engaged in the research, development,...more